We are a team of scientists on a mission to understand how the gut microbiome responds during periods of hormonal change. Led by Dr Siobhain O’Mahony, FemmeBiomeTM will explore changes in the gut microbiome during perimenopause and menopause and how these changes are linked to symptoms and risk of disease. Our goal is to develop scientifically backed, clinically validated interventions to improve women’s overall health and wellbeing.
By the year 2030 almost 1 billion women will be in perimenopause or the post-menopausal phase. Over 40 different symptoms have been described which can have a profound impact on women’s quality of life, performance at work and personal relationships.
Scientific research into menopause is vital to help women understand and manage symptoms and health risks associated with this phase of life.